SAC Capital Insider-Trading Cases: The Expert Call Before the Sell Orders

The SAC Capital insider-trading cases included a proposed SEC settlement of more than $600 million with CR Intrinsic Investors over alleged trades based on confidential Alzheimer’s drug-trial results. The SEC alleged that a doctor chosen to present those results to the public first supplied them to a portfolio manager through expert-network calls. If you work in fund research or compliance, the revealing part is the source behind a recommendation: what the consultant knew, what they said, and what the fund did next.

This page follows SAC’s corporate guilty pleas, the CR Intrinsic trading allegations and the information that people inside the research chain could explain. Our page on insider trading covers the broader connection between confidential information, duties and trades.

SAC Capital’s Corporate Pleas Reached the Research Chain

On November 8, 2013, the Justice Department reported corporate guilty pleas in a securities fraud and wire fraud case in Manhattan federal court. The four hedge fund management companies were S.A.C. Capital Advisors, L.P., S.A.C. Capital Advisors, LLC, CR Intrinsic Investors and Sigma Capital Management.

According to the Justice Department’s account of the criminal indictment, numerous employees obtained and traded on confidential information from 1999 through at least 2010. The alleged conduct involved securities of more than 20 public companies across several sectors. Research analysts and portfolio managers allegedly used the information themselves or recommended trades to portfolio managers or the fund’s owner.

The indictment described failures that began before an order reached the market. Hiring allegedly emphasized candidates with networks of public-company insiders. Management allegedly failed to question employees about trades that appeared to depend on inside information, while compliance measures failed to prevent or detect that trading, particularly before late 2009. We see the contradiction in those allegations: the business recruited for access, then failed to ask what that access delivered.

For a research or compliance employee, that reaches into everyday decisions about sources and recommendations. We examine what management wanted from a contact, what an employee said the contact supplied, and how the firm responded when the resulting trade raised questions.

The Alzheimer’s Drug Results Traveled Through Expert Calls

The SEC’s account of the CR Intrinsic allegations traced confidential clinical-trial information through a New York expert-network firm to a portfolio manager at the Stamford, Connecticut hedge fund adviser. The network arranged phone calls with a doctor who worked as a medical consultant. Elan Corporation and Wyeth, which were jointly developing the Alzheimer’s drug, had selected that doctor to present the final trial results to the public.

The SEC alleged that the doctor supplied safety data and eventually details about negative trial results about two weeks before their public release in July 2008. His role gave the calls their significance: the person discussing the drug also held the results the market was waiting to hear. In the SEC’s allegation, the public presenter became the fund’s private source.

The SEC alleged that the portfolio manager and CR Intrinsic then caused several hedge funds to sell more than $960 million in Elan and Wyeth securities in a little more than a week. The proposed settlement covered trades in those securities between July 21 and July 30, 2008.

For someone who worked around those calls, the medical content matters as much as the calendar. A consultation note may explain whether a discussion reached safety findings or the trial’s negative results, and who understood what the doctor had disclosed. We connect that explanation to the recommendation and the funds’ trading decisions, so the source’s access and the trader’s response can be understood together.

How Hard Is It to Prove Insider Trading?

The SAC Capital allegations show the connections an insider-trading investigation examines: a source with access to trial results, calls through an expert network, information supplied before public release and sales by the funds. A research analyst may understand the content of the recommendation while a compliance employee understands how the source was reviewed.

We examine communications and trading records with the person who understands what they meant at work. Consultation records and meeting notes can identify the subject discussed and the people involved. The recommendation can show how that information reached the investment decision. Order records and position changes can place the decision beside the public announcement. These are connections we investigate with you, using the records you know.

We examine the source’s responsibilities, the terms under which information was shared and what the recipient understood about those terms. An employee who knows the expert relationship may be able to explain those obligations alongside the consultation’s date and content.

The whistleblower perspective also reaches beyond the person who placed the trade. In The Significance of Whistleblowing as an Anti-Fraud Measure, published in the Journal of Forensic & Investigative Accounting in 2018, researchers found that whistleblowing was the most common detection method in their occupational-fraud sample. Their analysis also found a greater likelihood of whistleblower detection when more people participated in a scheme. Applied to a fund’s research chain, that finding gives us a reason to hear from the people around the recommendation, including those who can explain how a source was introduced or how a concern was handled.

The CR Intrinsic Settlement Followed Gains Into the Funds

From those securities sales, the SEC’s proposed civil settlement required CR Intrinsic to return $274,972,541, pay an equal civil penalty and pay $51,802,381 in prejudgment interest. The agency tied the gains to both profits and avoided losses from trades in portfolios managed by CR Intrinsic and S.A.C. Capital. It also identified fees that S.A.C. Capital received because of those gains.

The SEC added S.A.C. Capital Advisors and four managed hedge funds to its amended complaint as recipients of the alleged gains. That connected the portfolio manager’s information to money retained elsewhere in the business. The SEC credited assistance from the U.S. Attorney’s Office for the Southern District of New York, the FBI and FINRA. An insider who understands portfolio allocations or advisory fees may be able to explain where a trading benefit went after the order was executed.

The Value Was in Hearing the Result First

The information advantage in the CR Intrinsic allegations came from receiving trial results before their public presentation. A 2018 Wisconsin Law Review paper, Insider Trading and the Integrity of Mandatory Disclosure, explains a related problem in corporate reporting: companies compile and verify information before releasing it, creating an interval that someone with advance access can exploit. The paper puts the purpose of that disclosure plainly:

The same timing advantage runs through the SEC’s clinical-trial allegations. The fund could act before other investors heard the news. In the SEC’s allegation, the fund received the negative result while the market still awaited the presentation. Someone inside the consultation or investment process may know exactly how that interval became a trading opportunity.

Galleon Management offers a parallel in a different set of source relationships. The SEC’s October 2009 charging account traced information from contacts at Intel, McKinsey and IBM into fund trades. In the CR Intrinsic allegations, the route ran through a medical expert. For an insider, the common question is how information held inside one business reached an investment decision in another.

A Fund Insider’s Knowledge Can Support an SEC Report

If you recognize that movement of confidential information, we work with you on a securities fraud report grounded in your knowledge of the business. For a compliance employee, we also assess how your role and the way you learned the facts affect the reporting opportunity. Those questions belong in the conversation with our whistleblower experts, who bring in securities fraud whistleblower lawyers.

Under the SEC whistleblower program, eligible whistleblowers can share awards totaling 10% to 30% of qualifying sanctions collected when the covered action exceeds $1 million in monetary sanctions. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. Securities insider-trading reports belong to the SEC’s separate program, and we assess the opportunity your information supports.

You Know What the Expert Actually Said

If you can explain the confidential result behind a fund’s recommendation, talk with our whistleblower experts about the call, the source and the trade. We build the case with you and bring in securities fraud whistleblower lawyers who understand expert consultations, fund research and trading records. We stay beside you as that knowledge becomes the evidence for your strongest SEC whistleblower case.